Cargando…

Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice

Current vaccines against SARS-CoV-2 substantially reduce mortality, but protection against infection is less effective. Enhancing immunity in the respiratory tract, via mucosal vaccination, may provide protection against infection and minimise viral spread. Here, we report testing of a subunit vacci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ashhurst, Anneliese S., Johansen, Matt D., Maxwell, Joshua W. C., Stockdale, Skye, Ashley, Caroline L., Aggarwal, Anupriya, Siddiquee, Rezwan, Miemczyk, Stefan, Nguyen, Duc H., Mackay, Joel P., Counoupas, Claudio, Byrne, Scott N., Turville, Stuart, Steain, Megan, Triccas, James A., Hansbro, Philip M., Payne, Richard J., Britton, Warwick J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665025/ https://www.ncbi.nlm.nih.gov/pubmed/36379950 http://dx.doi.org/10.1038/s41467-022-34297-3

Ejemplares similares

Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2
por: Stewart, Erica L., et al.
Publicado: (2022)

Discovery of Cyclic Peptide Ligands to the SARS-CoV-2 Spike Protein Using mRNA Display
por: Norman, Alexander, et al.
Publicado: (2021)

A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection
por: Counoupas, Claudio, et al.
Publicado: (2021)

Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependent protection against pulmonary tuberculosis
por: Counoupas, Claudio, et al.
Publicado: (2020)

Intrapulmonary vaccination with delta-inulin adjuvant stimulates non-polarised chemotactic signalling and diverse cellular interaction
por: Ferrell, Kia C., et al.
Publicado: (2021)

Characterization of the Protective Immune Responses Conferred by Recombinant BCG Overexpressing Components of Mycobacterium tuberculosis Sec Protein Export System
por: Nisa, Annuurun, et al.
Publicado: (2022)

High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens
por: Counoupas, Claudio, et al.
Publicado: (2022)

Delta inulin-based adjuvants promote the generation of polyfunctional CD4(+) T cell responses and protection against Mycobacterium tuberculosis infection
por: Counoupas, Claudio, et al.
Publicado: (2017)

L-selectin-dependent and -independent homing of naïve lymphocytes through the lung draining lymph node support T cell response to pulmonary Mycobacterium tuberculosis infection
por: Daniel, Lina, et al.
Publicado: (2023)

A unique cytotoxic CD4(+) T cell‐signature defines critical COVID‐19
por: Baird, Sarah, et al.
Publicado: (2023)

Mycobacterium tuberculosis components expressed during chronic infection of the lung contribute to long-term control of pulmonary tuberculosis in mice
por: Counoupas, Claudio, et al.
Publicado: (2016)

Virulence Mechanisms of Mycobacterium abscessus: Current Knowledge and Implications for Vaccine Design
por: Ferrell, Kia C., et al.
Publicado: (2022)

Novel vaccination approaches to prevent tuberculosis in children
por: Triccas, James A., et al.
Publicado: (2016)

Stromal structure remodeling by B lymphocytes limits T cell activation in lymph nodes of Mycobacterium tuberculosis–infected mice
por: Daniel, Lina, et al.
Publicado: (2022)

Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing
por: Johansen, Matt D., et al.
Publicado: (2022)

Antiviral cyclic peptides targeting the main protease of SARS-CoV-2
por: Johansen-Leete, Jason, et al.
Publicado: (2022)

CXCR6-Deficiency Improves the Control of Pulmonary Mycobacterium tuberculosis and Influenza Infection Independent of T-Lymphocyte Recruitment to the Lungs
por: Ashhurst, Anneliese S., et al.
Publicado: (2019)

Clinical and Experimental Determination of Protection Afforded by BCG Vaccination against Infection with Non-Tuberculous Mycobacteria: A Role in Cystic Fibrosis?
por: Warner, Sherridan, et al.
Publicado: (2023)

CXCR3 Provides a Competitive Advantage for Retention of Mycobacterium tuberculosis-Specific Tissue-Resident Memory T Cells Following a Mucosal Tuberculosis Vaccine
por: Armitage, Ellis, et al.
Publicado: (2023)

PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection
por: Ashhurst, Anneliese S., et al.
Publicado: (2018)

Embedding of HIV Egress within Cortical F-Actin
por: Aggarwal, Anupriya, et al.
Publicado: (2022)

Virtual screening and in vitro validation of natural compound inhibitors against SARS-CoV-2 spike protein
por: Power, Helen, et al.
Publicado: (2022)

Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs
por: Loo, Lipin, et al.
Publicado: (2023)

Varicella zoster virus productively infects human natural killer cells and manipulates phenotype
por: Campbell, Tessa Mollie, et al.
Publicado: (2018)

TLR2, TLR4 AND MyD88 Mediate Allergic Airway Disease (AAD) and Streptococcus pneumoniae-Induced Suppression of AAD
por: Thorburn, Alison N., et al.
Publicado: (2016)

No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis
por: Quan, Diana H., et al.
Publicado: (2022)

Structural characterization of the ANTAR antiterminator domain bound to RNA
por: Walshe, James L, et al.
Publicado: (2022)

The Secreted Lipoprotein, MPT83, of Mycobacterium tuberculosis Is Recognized during Human Tuberculosis and Stimulates Protective Immunity in Mice
por: Kao, Fan F., et al.
Publicado: (2012)

Mobilization of HIV Spread by Diaphanous 2 Dependent Filopodia in Infected Dendritic Cells
por: Aggarwal, Anupriya, et al.
Publicado: (2012)

Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation
por: Stifter, Sebastian A., et al.
Publicado: (2016)

Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection
por: Muflihah, Heni, et al.
Publicado: (2021)

TLR2, but Not TLR4, Is Required for Effective Host Defence against Chlamydia Respiratory Tract Infection in Early Life
por: Beckett, Emma L., et al.
Publicado: (2012)

Harnessing Single Cell Sorting to Identify Cell Division Genes and Regulators in Bacteria
por: Burke, Catherine, et al.
Publicado: (2013)

Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes
por: Stelzer-Braid, Sacha, et al.
Publicado: (2020)

Exposure to the gut microbiota from cigarette smoke-exposed mice exacerbates cigarette smoke extract-induced inflammation in zebrafish larvae
por: Morris, Simone, et al.
Publicado: (2021)

Development of a novel angiotensin converting enzyme 2 stimulator with broad implications in SARS-CoV2 and type 1 diabetes
por: Rajapakse, Niwanthi, et al.
Publicado: (2023)

Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection
por: Khoury, David S., et al.
Publicado: (2023)

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
por: Cromer, Deborah, et al.
Publicado: (2022)

Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability
por: Burnett, Deborah L., et al.
Publicado: (2021)

Kinetics of HIV-1 capsid uncoating revealed by single-molecule analysis
por: Márquez, Chantal L, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hkvlkrlcgfvo1ol2vjmhm1uboe